[Effect of ethyl alpha-p-chlorophenoxyisobutyrate (Clofibrate) on lipids, cholesterol and uric acid in diabetes mellitus].
D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002087:Butyrates / Q000627:therapeutic use*; D002784:Cholesterol; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008055:Lipids; D008297:Male; D008875:Middle Aged; D014527:Uric Acid
D000924:Anticholesteremic Agents; D002087:Butyrates; D008055:Lipids; D014527:Uric Acid; D002784:Cholesterol
Effet de l'éthyl-alpha-p-chlorophénoxy-isobutyrate (clofibrate) sur les lipides, le cholestérol et l'acide urique dans le diabète sucré.